Healthy Participant Clinical Trial
Official title:
How Does Smoking Effect the Clinical Performance of a Universal Adhesive Used With Different Application Modes in Non Carious Cervical Lesions?
Verified date | March 2021 |
Source | Hacettepe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study was to evaluate the influence of smoking on the clinical performance of a universal adhesive used with different application modes in non-carious cervical lesions.
Status | Active, not recruiting |
Enrollment | 47 |
Est. completion date | January 1, 2025 |
Est. primary completion date | March 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Patients were 18 years of age or older, - good general health, - acceptable oral hygiene level, - no possible health problems (such as allergies) related to resin-based restorations, - at least three non-carious cervical lesions with at least 20 teeth in the occlusion. - The depth of the lesions should be at least 1 mm, without carious, not previously restored, having teeth with vital, enamel and dentin tissue. - Patients who smoke at least 10 cigarettes per day, however patients in non-smokers have never smoked before. Exclusion Criteria: - Participant had fewer than 20 teeth, - having poor oral hygiene, - uncontrolled periodontal disease, - xerostomia, - diagnosis of bruxism, - pregnancy or breastfeeding possible health problems (such as allergy) related to resin-based restorations - having severe systemic disease, - having bleaching treatment or orthodontic treatment. |
Country | Name | City | State |
---|---|---|---|
Turkey | Hacettepe University Faculty of Dentistry | Ankara |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Plaque Index | When evaluating Plaque Index scores, only the amount of plaque in the gingival area of the tooth surfaces is taken into account. Plaque amount is evaluated with periodontal probe and scored.
Plaque Index Scores 0 When examined with a periodontal probe at the edge of the gum, no plaque accumulation is seen. When examined with a periodontal probe, it is seen that there is plaque accumulation. Visible plaque accumulation at the edge of the gum but not completely filled in the interdental area. An easily visible plaque accumulation on the gum edge and towards the coronal, completely filling the interdental zone |
baseline (one week)-18-month | |
Other | Gingival index | The periodontal probe is used to evaluate whether there is inflammation, discoloration, and gingival bleeding along the gingival sulcus.
Gingival Index Scores 0 Healthy gums. Mild inflammation: Slight discoloration and mild edema, but no bleeding on probing. Moderate inflammation: The gingiva is shiny, there is slight redness, edema and bleeding on the gum when touched with the sond. Severe inflammation: There is marked redness, edema and ulceration of the gums, the gum tends to bleed spontaneously. |
baseline (one week)-18-month | |
Primary | Retention | According to the usphs criteria, retention indicates whether a restorative material is functional in the oral environment, and is the most important criterion by which we can evaluate the success of the material.
Alpha: Retained. Charlie: Mobile or missing; clinically unacceptable. |
baseline (one week)-18-month | |
Primary | Marginal Discoloration | Evaluation of color changes in restoration margins and linear staining along restoration margins. Alfa: No discoloration along the margin. Bravo: Slight and superficial staining (removable, usually localized). Charlie: Deep staining cannot be polished away. | baseline (one week)-18-month | |
Primary | Marginal Adaptation | The marginal adaptation criterion evaluates the complete achievement of tooth-restoration integrity.
Alpha: Undetectable. Bravo: Visible evidence of a crevice along the margin, dentin not exposed, clinically acceptable. Charlie: Explorer penetrates into crevice, dentin is exposed; clinically unacceptable. |
baseline (one week)-18-month | |
Primary | Color match | Evaluating whether the restoration and adjacent tooth tissue color is compatible.
Alpha:Matches tooth. Bravo: Acceptable mismatch. Charlie:Unacceptable mismatch. |
baseline (one week)-18-month | |
Primary | Post-op Hypersensitivity | It is the evaluation of sensitivity after dental treatment. Alpha: Hypersensitivity absent. Charlie: Present; clinically unacceptable. | baseline (one week)-18-month | |
Primary | Secondary Caries | In this criterion, the dark colored area that occurs under the tooth tissue surface and in the tooth tissue adjacent to the restoration is defined as caries.
Alpha: Caries absent. Charlie: Present; clinically unacceptable. |
baseline (one week)-18-month | |
Secondary | VAS scale | Sensitivity to air was assessed by appling a stream of compressed air for three second 1 cm away from the tooth surface while shielding the neighboring teeth with the fingers. After this application, individuals are asked to evaluate the sensitivity of the tooth according to the Visual Analog Scale (VAS). VAS consists of a straight line 10 centimeters (cm) long. The left end of the line is 0 and it means "no pain, the right end is 10", meaning unbearable pain. With the help of this scale, the pain levels in the teeth of individuals with hypersensitivity can be determined. | baseline (one week)-18-month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05311865 -
Transmission of Covid-19 During Clubbing Events in Closed Places
|
N/A | |
Recruiting |
NCT05520216 -
Effect of Rib Cage and Spine Mobility on Maximum Breath-Hold Time
|
||
Completed |
NCT06087055 -
Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
|
Phase 1 | |
Completed |
NCT04962022 -
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
|
Phase 1 | |
Completed |
NCT04962230 -
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
|
Phase 1 | |
Completed |
NCT05450549 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT04814836 -
Laser Etching Effect on Application Mode of Universal Adhesive
|
N/A |